789 related articles for article (PubMed ID: 30558648)
41. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.
Harris JA; Jain S; Ren Q; Zarineh A; Liu C; Ibrahim S
Diagn Pathol; 2012 Jan; 7():12. PubMed ID: 22289504
[TBL] [Abstract][Full Text] [Related]
42. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis.
Allison E; Edirimanne S; Matthews J; Fuller SJ
Oncol Ther; 2023 Mar; 11(1):27-48. PubMed ID: 36484945
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma.
Lee WJ; Lee MH; Kim HT; Won CH; Lee MW; Choi JH; Chang SE
Melanoma Res; 2019 Oct; 29(5):501-509. PubMed ID: 30575644
[TBL] [Abstract][Full Text] [Related]
44. Exploring the role CD163-labeled TAMs and FOXP3-labeled Tregs in different types of breast cancer: Reflections and putative benefits.
Shash LS; M Kamal KA; Abd Raboh NM
Indian J Pathol Microbiol; 2021; 64(1):28-37. PubMed ID: 33433406
[TBL] [Abstract][Full Text] [Related]
45. Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.
Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
Clin Transl Oncol; 2021 Dec; 23(12):2513-2525. PubMed ID: 34089486
[TBL] [Abstract][Full Text] [Related]
46. The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.
Kong LQ; Zhu XD; Xu HX; Zhang JB; Lu L; Wang WQ; Zhang QB; Wu WZ; Wang L; Fan J; Tang ZY; Sun HC
PLoS One; 2013; 8(3):e59771. PubMed ID: 23555776
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of the infiltration of CD163
Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J
Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574
[TBL] [Abstract][Full Text] [Related]
48. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
[TBL] [Abstract][Full Text] [Related]
49. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
[TBL] [Abstract][Full Text] [Related]
50. Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer.
Chung FT; Lee KY; Wang CW; Heh CC; Chan YF; Chen HW; Kuo CH; Feng PH; Lin TY; Wang CH; Chou CL; Chen HC; Lin SM; Kuo HP
Int J Cancer; 2012 Aug; 131(3):E227-35. PubMed ID: 22174092
[TBL] [Abstract][Full Text] [Related]
51. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK
J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084
[TBL] [Abstract][Full Text] [Related]
52. Plasmablastic Lymphomas: Characterization of Tumor Microenvironment Using CD163 and PD-1 Immunohistochemistry.
Ahn JS; Al-Habib A; Vos JA; Sohani AR; Barboza-Quintana O; Flores JP; Wen S; Rosado FG
Ann Clin Lab Sci; 2020 Mar; 50(2):213-218. PubMed ID: 32366559
[TBL] [Abstract][Full Text] [Related]
53. Human breast cancer cells educate macrophages toward the M2 activation status.
Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA
Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145
[TBL] [Abstract][Full Text] [Related]
54. Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery.
Garvin S; Oda H; Arnesson LG; Lindström A; Shabo I
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1253-1263. PubMed ID: 29725763
[TBL] [Abstract][Full Text] [Related]
55. The prognostic value of tumour-associated macrophages in Non-Hodgkin's lymphoma: A systematic review and meta-analysis.
Xu X; Li Z; Liu J; Zhu F; Wang Z; Wang J; Zhang J; Wang H; Zhai Z
Scand J Immunol; 2020 Jan; 91(1):e12814. PubMed ID: 31419843
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer.
Gwak JM; Jang MH; Kim DI; Seo AN; Park SY
PLoS One; 2015; 10(4):e0125728. PubMed ID: 25884955
[TBL] [Abstract][Full Text] [Related]
57. Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma.
Komohara Y; Niino D; Saito Y; Ohnishi K; Horlad H; Ohshima K; Takeya M
Cancer Sci; 2013 Jul; 104(7):945-51. PubMed ID: 23557330
[TBL] [Abstract][Full Text] [Related]
58. Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.
Hasita H; Komohara Y; Okabe H; Masuda T; Ohnishi K; Lei XF; Beppu T; Baba H; Takeya M
Cancer Sci; 2010 Aug; 101(8):1913-9. PubMed ID: 20545696
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathological correlation of tumor-associated macrophages in Ewing sarcoma.
Handl M; Hermanova M; Hotarkova S; Jarkovsky J; Mudry P; Shatokhina T; Vesela M; Sterba J; Zambo I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Mar; 162(1):54-60. PubMed ID: 29170560
[TBL] [Abstract][Full Text] [Related]
60. High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer.
Zhang Y; Cheng S; Zhang M; Zhen L; Pang D; Zhang Q; Li Z
PLoS One; 2013; 8(9):e76147. PubMed ID: 24098773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]